Click on headlines below to download research
Positive momentum
Britvic | 20/05/2022
During H122, Britvic witnessed double-digit revenue growth and volume and price increases in all business units and strong momentum across core brands.…
Stable performance year to date
Claranova | 20/05/2022
Claranova reported a revenue decline of 1% for the nine months to 31 March 2022 (9M22), reflecting a strong performance in Avanquest offset by a tougher…
IV TPOXX receives FDA Approval
SIGA Technologies | 20/05/2022
SIGA Technologies announced the FDA approval for its intravenous (IV) formulation of tecovirimat (TPOXX), an antiviral drug for the treatment of smallpox.…
IV TPOXX receives FDA Approval
SIGA Technologies | 20/05/2022
SIGA Technologies announced the FDA approval for its intravenous (IV) formulation of tecovirimat (TPOXX), an antiviral drug for the treatment of smallpox.…
Attractive income and long-term outperformance
Murray Income Trust | 20/05/2022
Murray Income Trust (MUT) invests mainly in UK equities and aims to provide a high and growing income, combined with capital growth. Its quality bias has…
Eye health portfolio targets large markets
Nicox | 19/05/2022
Nicox’s lead candidate NCX-470 continues to advance in the Mont Blanc Phase III trial targeting the topical treatment of glaucoma, having recently…
First patient dosed with FR104/VEL-101
OSE Immunotherapeutics | 19/05/2022
OSE Immunotherapeutics has announced that the first participant in a Phase I study has been dosed with the company’s CD28-targeting antibody fragment,…
Executive interview
1Spatial – executive interview | 19/05/2022
In this interview, Claire Milverton, CEO discusses 1Spatial’s unique position at the intersection of two large, high-growth markets, geospatial data…
Evolving the sales model
Evolva | 18/05/2022
Evolva has signed a distribution agreement to jointly develop the Brazilian market for resveratrol with its new partner, Tovani Benzaquen, a distributor…
Q122 results – good cost control
Pan American Silver | 18/05/2022
Pan American Silver’s (PAAS’s) Q122 financial results were supported by strong gold and silver sales, while production was affected by the…
Guidance edged up
Dentsu Group | 18/05/2022
Dentsu has edged up its FY22 guidance for organic growth to a range of 4–5%, from 4% previously, following a strong Q122 performance, particularly…
Encouraging start to FY22
Tinexta | 18/05/2022
Tinexta reported a good start to the year with continued strong organic revenue growth in Q122. This was further boosted by first-time contributions from…
Preparing for accelerating growth
TIE Kinetix | 18/05/2022
TIE Kinetix’s H122 results showed that as it transitions to a 100% software as a service (SaaS) business model, the company is incurring costs this…
A strong opening
Endeavour Mining | 17/05/2022
Endeavour’s Q122 adjusted net EPS from continuing operations were within 4% of our prior estimate, at US$0.49/share, with gold sold exceeding our…
Strong loan momentum in Q122
Secure Trust Bank | 17/05/2022
Secure Trust Bank disclosed in its Q122 trading update that balance sheet momentum is strong and the business remains on track to deliver on management’s…
Accelerating sustainability
Melrose Industries | 17/05/2022
Melrose embraces sustainability through two avenues: internally through continuous development of its ESG practices and externally through the development…
Profit outlook maintained for FY22
Greggs | 17/05/2022
Greggs’ (GRG) AGM trading update (first 19 weeks of FY22) indicates it continues to trade well in what has undoubtedly become a more challenging…
Empowering sustainability
Newmont Corporation | 17/05/2022
Despite slightly lower production and higher costs in Q122, Newmont’s financial performance was within 6% of our prior expectations and exceeded…
Looking forward to a better FY22/23
Borussia Dortmund | 17/05/2022
Borussia Dortmund’s football season finished on 14 May 2022 with another (comfortable) second place in the Bundesliga confirming qualification for…
Broadening the UK bathroom product offering
Norcros | 17/05/2022
The acquisition of Grant Westfield (GW) is a typical Norcros deal: profitable, strongly complementary to the existing product offer and has excellent ongoing…
Samsung versus Nanoco: Round 1 to Nanoco
Nanoco Group | 17/05/2022
The ruling by the US Patent Trial and Appeal Board (PTAB) in favour of Nanoco in respect of all 47 claims in the five patents underpinning its litigation…
Payment Assist acquisition
Manx Financial Group | 17/05/2022
Manx Financial Group (MFG) has announced it is buying 50.1% of Payment Assist, a UK point-of-sale lender, for £4m. Through Conister Bank, MFG has…
Positive interim data for DCP-001
Immunicum | 17/05/2022
Immunicum has reported positive interim data from the ongoing Phase II ADVANCE II clinical trial of DCP-001 as an acute myeloid leukaemia (AML) maintenance…
New governance structure
Nicox | 17/05/2022
Nicox has announced a new governance structure that will separate the functions of CEO and chairman. Andreas Segerros, an experienced global pharma executive,…
The King of ‘Dulltech’
HgCapital Trust | 16/05/2022
HgCapital Trust’s (HGT’s) sector expertise has allowed it to consistently deliver strong performance, with a 10-year NAV total return (TR)…
A year of consolidation
bet-at-home | 16/05/2022
bet-at-home (BAH) is an established European online sports betting and casino gaming provider. It largely operates in regulated markets and seeks formal…
Strong momentum in Q123
Unbound Group | 16/05/2022
Unbound Group’s (UBG’s) Q123 trading update to the end of April 2022 shows continuing strong momentum, in contrast to recent trends in the…
US momentum offset by one-time items
OpGen | 16/05/2022
OpGen reported Q122 revenues of $470k, compared to $830k in the prior year period. The decline was largely attributable to the discontinuation of the FISH…
Added to MSCI Global Standard indices
Mytilineos | 16/05/2022
It was announced on Friday that Mytilineos is one of just two Greek companies that were added to the MSCI Greece index, which forms part of the MSCI Global…
Strong Q1 results
Hellenic Petroleum | 16/05/2022
Hellenic Petroleum reported Q1 adjusted EBITDA of €99m, a 54% increase year-on-year and c 20% ahead of consensus (€82m; based on four analysts).…
UV1 Phase II data flow creeps closer
Ultimovacs | 13/05/2022
Management provided an update on the clinical progress of lead candidate UV1 in six clinical trials in conjunction with its Q122 financial results. Enrolment…
Screening platform continues to bear fruit
IRLAB Therapeutics | 13/05/2022
IRLAB Therapeutics’ Q122 report recapped many of the research and development highlights shared on the company’s inaugural capital markets…
Executive interview
Applied Graphene Materials - executive interview | 13/05/2022
Applied Graphene Materials develops graphene dispersions that are used by customers to enhance the properties of coatings, composites and functional materials.…
Division on schedule
Technicolor | 12/05/2022
Technicolor’s Q122 results show broadly flat group revenues (at constant exchange rates) with a good step up in EBITDA as the mix shifts towards…
Keeping the faith during stock market volatility
Canadian General Investments | 12/05/2022
Canadian General Investments (CGI) has been managed by Greg Eckel at Morgan Meighen & Associates (MMA) since 2009. Despite elevated levels of stock market…
Executive interview
Basilea Pharmaceutica - executive interview | 12/05/2022
Basilea Pharmaceutica is a Switzerland-based biopharmaceutical company, established in 2000 as a spin-out from Roche with the divestment of its anti-infective…
US momentum accelerating
Mirriad Advertising | 12/05/2022
Mirriad is making significant progress in building partnerships on the content supply side and with blue-chip advertisers and agencies, particularly in…
Upgrading revenue forecasts
Treatt | 12/05/2022
Treatt has witnessed another good performance: H1 revenue grew by an impressive 9%, with growth across five of Treatt’s six categories. Management…
Positive return to core strategy
Phoenix Spree Deutschland | 12/05/2022
Driven by a continuing housing shortage, Berlin residential property rents and condominium prices have continued to increase over the past year. Having…
EVT801, Kazia’s second programme, and capital markets
EVT801, Kazia’s second programme, and capital markets | 11/05/2022
In the third part of our Edison TV series on Kazia Therapeutics (KZIA), John Friend, CMO, and James Garner, CEO, discuss the company’s second pipeline…
FY21 was in line but headwinds remain
Ocean Wilsons Holdings Limited | 11/05/2022
Ocean Wilsons (OCN) is an investment holding company with a controlling interest in Wilson Sons (WSON), a long-established Brazilian maritime services…
Catalysts approaching for DCP-001
Immunicum | 11/05/2022
Immunicum specialises in the research and development of novel immunotherapies that target hard-to-treat tumours and tumour recurrence. In its pipeline…
Operational gearing shines through
Datatec | 11/05/2022
Today’s trading update follows the group’s post-close trading update in March 2022, where management confirmed FY22 group revenue would be…
Going to California with Caltrans on my mind
1Spatial | 11/05/2022
1Spatial continues its US expansion with the announcement of a contract win to support replacing the Transportation System Network (TSN) for the California…
Paxalisib: Beyond glioblastoma and commercial opportunity
Paxalisib: Beyond glioblastoma and commercial opportunity | 10/05/2022
In the second part of this three-episode Edison TV series, Kazia Therapeutics (KZIA), dives deeper into paxalisib for additional indications beyond glioblastoma.…
Closer to delivering customer samples
Ensurge Micropower | 10/05/2022
Ensurge Micropower has provided a detailed update on its progress on manufacturing the world’s first milliampere hour scale solid-state lithium microbatteries,…
Building a more diversified investment bank
Numis Corporation | 10/05/2022
The challenging market background in Q222 put a brake on capital markets transactions and significantly affected Numis’s first half results but also…
Back on track for $1bn revenue
4imprint Group | 09/05/2022
4imprint has announced that trading over the first four months of the year was stronger than anticipated. Both order volumes and average order values are…
Meet Kazia’s management team and paxalisib, Kazia’s lead programme
Meet Kazia’s management team and hear about paxalisib, Kazia’s lead programme | 09/05/2022
Kazia Therapeutics (KZIA) is an oncology-focused drug development company. Its drug candidates are designed to treat cancers which are poorly served by…
Successfully growing with tenants
Impact Healthcare REIT | 09/05/2022
Impact Healthcare REIT’s recent results provided strong evidence of the robustness of its strategy and the resilience of its tenants. Indexed rent…
Product and international expansion on track
SIGA Technologies | 09/05/2022
SIGA has reported Q122 revenues of $10.5m, up 119% y-o-y, driven by the first IV TPOXX deliveries to the US government. It also achieved key milestones…
Useful insights from CANOPY-1 data
Cantargia | 09/05/2022
Novartis presented full results from its CANOPY-1 trial with canakinumab (anti-IL1beta; Cantargia’s CAN04 is an anti-IL1RAP with complete inhibition…
2022 objectives
Webinar: Loop Energy - 2022 objectives | 09/05/2022
Loop Energy (TSE: LPEN) designs, manufactures, installs and maintains hydrogen fuel cells and the systems which integrate them. Once it has established…
Momentum continuing unabated
CLIQ Digital | 06/05/2022
CLIQ Digital (CLIQ) has had a positive start to the year, with Q122 results providing an early indication that it is on track to meet its guidance for…
A strong recovery in dividend income for H122
Henderson Far East Income | 06/05/2022
Henderson Far East Income (HFEL) focuses on providing investors with a high and growing level of income, with capital appreciation an important consideration…
Forecasts unchanged and outlook improved
Sylvania Platinum | 06/05/2022
Sylvania’s end March 2022 cash balance improved by 25.5% to US$138m and Q322 revenue increased by 17% as a result of higher platinum group metal…
Executive interview
Portobello SpA – executive interview | 06/05/2022
Portobello SpA is a relatively young company with a unique business model. It is a value-based retailer of general merchandise including homewares, electricals,…
Good start to the year despite many challenges
Kendrion | 05/05/2022
Kendrion’s revenue growth of 13% in Q1 was better than we expected, despite increased uncertainty in its markets. Industrial remains the star performer…
Focusing in on 1L NSCLC and COVID-19
BerGenBio | 05/05/2022
BerGenBio (BGBIO) has announced an updated business strategy for its lead drug candidate, oral AXL inhibitor bemcentinib, which will focus on first-line…
Progressing the strategy
OPAP | 05/05/2022
OPAP is a listed gaming operator with 100% pre-paid exclusive retail licences, which provide significant barriers to entry and strong recurring cash flow.…
Executive interview
CentralNic - executive interview | 05/05/2022
CentralNic is a leading global domain name services and online marketing company, operating through two divisions: Online Presence, which provides businesses…
Fine tuning forecasts ahead of Q1 results
Wheaton Precious Metals | 05/05/2022
Wheaton Precious Metals’ (WPM) Q122 results are scheduled for release on Thursday 5 May, after the market close in Toronto (approximately 22.30 London…
ESG interview with Ken Sickles and Mignon Senuta of Digimarc
ESG interview with Ken Sickles and Mignon Senuta of Digimarc | 04/05/2022
Digimarc is a pioneer of the Digimarc Platform, which enables a more efficient, reliable and economical means of automatic identification. End-use applications…
Q3 trading update confirms pipeline progression
Arovella Therapeutics | 04/05/2022
Arovella’s Q322 trading update confirms the progress of its development pipeline, with an emphasis on its lead asset, ALA-101. With the selection…
Maricunga progress and WA asset demerger
Lithium Power International | 04/05/2022
Lithium Power International’s (LPI’s) Q322 activities report suggests continued progress on its 52%-owned Maricunga lithium project in Chile.…
Wressle continues to deliver
Egdon Resources | 04/05/2022
Egdon Resources’ Wressle-1 well continues to produce above expectation, delivering 760–800bopd (228–240bopd net) during the six months…
Renewed focus on anti-infectives
Basilea Pharmaceutica | 04/05/2022
In February, Basilea announced a strategic refocusing on its core anti-infective business and is exploring strategic options for its oncology assets. Strong…
Webinar
Aditxt business update with Amro Albanna, co-founder and CEO | 04/05/2022
Aditxt is a biotech innovation company developing technologies focused on mapping and reprogramming the immune system. The company’s immune mapping…
Executive interview
Nanoco – executive interview | 04/05/2022
Nanoco’s CEO, Brian Tenner, begins this interview with an overview of Nanoco’s technology and then discusses why the company is suing Samsung…
FY21 results show continued solid recovery
S Immo | 04/05/2022
S Immo’s FY21 results saw a gross profit recovery very close to 2019 and EPS setting an all-time record of €3.24 per share. This was accompanied…
Well positioned for growth
Triple Point Social Housing REIT | 04/05/2022
Triple Point Social Housing REIT (SOHO) delivered a strong performance in FY21 with its portfolio of long lease specialised social housing assets continuing…
ESG specialist manager delivering its strategy
Gresham House | 04/05/2022
Gresham House has a strong position in alternative asset management with a sustainability focus, areas that are expected to experience continued strong…
Acquisition of AxesInMotion
Media and Games Invest | 03/05/2022
MGI has announced the acquisition of AxesInMotion, a Spanish free-to-play mobile games developer of racing games for €55m in cash up-front, plus…
Executive interview
Arcadis – executive interview | 03/05/2022
Arcadis trades at a discount to both its larger European peers and its North American competitors, with the discount even wider versus the latter group.…
Weaker European business drives downgrades
EML Payments | 03/05/2022
With its Q322 trading update, EML Payments downgraded its guidance for FY22. A number of factors have combined to weigh on revenue and increase overheads.…
First view of an emerging champion
Agnico Eagle Mines | 03/05/2022
On an underlying basis, Agnico Eagle Mines’ (AEM’s) Q122 revenue of US$1,325.7m, EBITDA of US$583.8m, pre-tax profits of US$300.4m and adjusted…
Sticking to the successful long-term strategy
abrdn UK Smaller Companies Growth Trust | 03/05/2022
abrdn UK Smaller Companies Growth Trust (AUSC) is managed by two of abrdn’s small-cap specialists: Harry Nimmo (since September 2003) and Abby Glennie…
Steady progress on all fronts
OSE Immunotherapeutics | 03/05/2022
OSE Immunotherapeutics (OSE) and its three pharma partners have made progress with all key clinical and preclinical assets. The final analysis of the data…
Sensing another record quarter of AI SaaS
SenSen Networks | 03/05/2022
SenSen (SNS), an Australian-based artificial intelligence company, reported another quarter of record cash receipts, growing 109% y-o-y to A$1.7m in Q322.…
A core option for Asian income and capital growth
abrdn Asian Income Fund | 03/05/2022
abrdn Asian Income Fund (AAIF) is a core option for investors seeking a combination of higher income and growing capital and income from Asian equities.…
Notable launches of high-value rare cannabinoids
InMed Pharmaceuticals | 03/05/2022
InMed Pharmaceuticals (INM) continues its transition from a pure-play pharma R&D firm to one also benefiting from commercial sales into the health and…
Termination of coverage
Termination of coverage - Brooge Energy | 29/04/2022
Edison Investment Research is terminating coverage on Brooge Energy (BROG), Tyman (TYMN), SymBio Pharmaceuticals (4582), Aspire Global (0EAZ), CiiTECH…
Termination of coverage
Termination of coverage - SymBio Pharmaceuticals | 29/04/2022
Edison Investment Research is terminating coverage on Brooge Energy (BROG), Tyman (TYMN), SymBio Pharmaceuticals (4582), Aspire Global (0EAZ), CiiTECH…
Termination of coverage
Termination of coverage - Tyman | 29/04/2022
Edison Investment Research is terminating coverage on Brooge Energy (BROG), Tyman (TYMN), SymBio Pharmaceuticals (4582), Aspire Global (0EAZ), CiiTECH…
Termination of coverage
Termination of coverage - Aspire Global | 29/04/2022
Edison Investment Research is terminating coverage on Brooge Energy (BROG), Tyman (TYMN), SymBio Pharmaceuticals (4582), Aspire Global (0EAZ), CiiTECH…
Termination of coverage
Termination of coverage - Marshall Motor Holdings | 29/04/2022
Edison Investment Research is terminating coverage on Brooge Energy (BROG), Tyman (TYMN), SymBio Pharmaceuticals (4582), Aspire Global (0EAZ), CiiTECH…
Positive Q122 trading update
Creo Medical | 29/04/2022
Creo Medical has released a Q122 trading update and is scheduled to publish FY21 results in early May 2022. Management highlighted the increased demand…
Executive interview
Osirium Technologies – executive interview | 29/04/2022
UK-based Osirium Technologies designs and supplies subscription-based cybersecurity software, specialising in privileged access security. Osirium’s…
ESG repositioning continues
Riverstone Credit Opportunities Income | 29/04/2022
Riverstone Credit Opportunities Income (RCOI) is a closed-end fund that invests in mid-market energy company credit mostly via direct loans. This is a…
A compelling story at an attractive discount
Molten Ventures | 29/04/2022
Molten Ventures continues to deliver strong returns, fully meeting its guidance for FY22, though the current environment is clearly more challenging than…
Progress with organic and acquisition-led growth
Primary Health Properties | 29/04/2022
Coinciding with its FY21 AGM, Primary Health Properties (PHP) has provided a trading update for the quarter ending 31 March 2022 (Q122). During the period…
A great year, and better ones ahead?
Gresham House Energy Storage Fund | 28/04/2022
Gresham House Energy Storage Fund (GRID) invests in a diversified portfolio of utility-scale battery energy storage systems (BESS) in the UK and Ireland.…
Establishing a strong track record
YOC | 28/04/2022
YOC issued its FY22 guidance in its FY21 results, anticipating for accelerated revenue growth and margin improvements in the year. Performance will continue…
Refining forecasts ahead of results
Endeavour Mining | 28/04/2022
Endeavour’s Q122 results are scheduled for distribution to the market on 5 May. Prior to their release, we have refined our forecasts for both the…
Spring into a new strategy
Basilea Pharmaceutica | 28/04/2022
Basilea Pharmaceutica has announced that it will in-license a pre-clinical programme of novel broad spectrum anti-fungals targeting difficult-to-treat…